OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(25)
Publication Date
Release Date
2023
(4)
2021
(4)
2016
(4)
2024
(2)
2022
(2)
2020
(2)
2017
(2)
2025
(1)
2018
(1)
2015
(1)
2014
(1)
2013
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration.
Not available
S-EPMC11812128
|
biostudies-literature
Cite
Coordinated regulation of acid resistance in Escherichia coli.
Not available
S-EPMC5217608
|
biostudies-literature
Cite
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Not available
S-EPMC8189692
|
biostudies-literature
Cite
Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia.
Not available
S-EPMC7780481
|
biostudies-literature
Cite
Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling.
Not available
S-EPMC6925349
|
biostudies-literature
Cite
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Not available
S-EPMC10436185
|
biostudies-literature
Cite
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Not available
S-EPMC9634600
|
biostudies-literature
Cite
Are large clinical trials in orthopaedic trauma justified?
Not available
S-EPMC5909275
|
biostudies-literature
Cite
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
Not available
S-EPMC10033295
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets